LDL-C/HDL-C is associated with ischaemic stroke in patients with non-valvular atrial fibrillation: a case-control study

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1476-511X
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
LDL-C/HDL-C is associated with ischaemic stroke in patients with non-valvular atrial fibrillation: a case-control study ; volume:19 ; number:1 ; day:7 ; month:10 ; year:2020 ; pages:1-11 ; date:12.2020
Lipids in health and disease ; 19, Heft 1 (7.10.2020), 1-11, 12.2020

Creator
Zhang, Xiao-Xue
Wei, Meng
Shang, Lu-Xiang
Lu, Yan-Mei
Zhang, Ling
Li, Yao-Dong
Zhang, Jiang-Hua
Xing, Qiang
Tu-Erhong, Zu Kela
Tang, Bao-Peng
Zhou, Xian-Hui
Contributor
SpringerLink (Online service)

DOI
10.1186/s12944-020-01392-7
URN
urn:nbn:de:101:1-2020112219014480531041
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Zhang, Xiao-Xue
  • Wei, Meng
  • Shang, Lu-Xiang
  • Lu, Yan-Mei
  • Zhang, Ling
  • Li, Yao-Dong
  • Zhang, Jiang-Hua
  • Xing, Qiang
  • Tu-Erhong, Zu Kela
  • Tang, Bao-Peng
  • Zhou, Xian-Hui
  • SpringerLink (Online service)

Other Objects (12)

Psychiatric symptoms in patients with non-valvular atrial fibrillation

Psychiatric symptoms in patients with non-valvular atrial fibrillation

Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation

Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation

Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation

Correction: Psychiatric symptoms in patients with non-valvular atrial fibrillation

Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation

Use of Chronic Medications Among Patients with Non-Valvular Atrial Fibrillation

Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran

Anticoagulation for non-valvular atrial aibrillation – towards a new beginning with ximelagatran

Non-valvular left ventricular papillary fibroelastoma in a patient with recurrent stroke

Non-valvular left ventricular papillary fibroelastoma in a patient with recurrent stroke

Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation

Morphology and location of thrombus and sludge in patients with non-valvular atrial fibrillation

Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation

Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation

Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation

Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation

MicroRNA profiling in the left atrium in patients with non-valvular paroxysmal atrial fibrillation

MicroRNA profiling in the left atrium in patients with non-valvular paroxysmal atrial fibrillation

Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation

Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation

Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design

Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design

Related objects